`Gleevec` Is Ready to Go!
The remedy for the chronic Myelongenous Leukemia (CML) patients, Gleevec, is packaged in a drug manufacture in Ansan, Kyonggi. This drug, developed by Novartis Pharmaceuticals in Swiss, will sell to the Korean patients from early next month.
Headline News
- Ukraine says N. Korea’s first troops arrive in Kursk
- N. Korea begins installing barriers on Donghae Line after 'bombing show'
- K-defense operating profit expected to jump by 200% in Q3
- Seoul City launches DDP rooftop tours, celebrating 10th anniversary
- Ahn Jung-geun’s historic writings return to Korea in 15 years
About Dong-A Ilbo